Centene Corp Files 8-K for Regulation FD Disclosure

TL;DR

Centene filed an 8-K for Reg FD. No specifics yet.

AI Summary

Centene Corporation filed an 8-K on September 10, 2024, reporting an event that occurred on September 9, 2024. The filing is categorized under Regulation FD Disclosure, indicating it pertains to material information that could affect investor decisions. No specific financial transactions or operational updates are detailed in the provided excerpt.

Why It Matters

This filing signals Centene Corporation is disclosing material information to the public, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate immediate risk.

Key Players & Entities

• CENTENE CORP (company) — Filer
• 0001071739-24-000170 (other) — Accession Number
• September 10, 2024 (date) — Date of Report
• September 9, 2024 (date) — Date of earliest event reported
• Delaware (location) — State of Incorporation
• 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (address) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange
• $6.80 — er share (EPS) guidance of greater than $6.80; reiterate the shift of 20 to 30 cents
• $1.31 — ects Q3 adjusted diluted EPS of between $1.31 to $1.41, with the remainder of the 202
• $1 — djusted diluted EPS of between $1.31 to $1.41, with the remainder of the 2024 full

Filing Documents

• cnc-20240910.htm (8-K) — 36KB
• 0001071739-24-000170.txt ( ) — 160KB
• cnc-20240910.xsd (EX-101.SCH) — 2KB
• cnc-20240910_lab.xml (EX-101.LAB) — 21KB
• cnc-20240910_pre.xml (EX-101.PRE) — 12KB
• cnc-20240910_htm.xml (XML) — 3KB

01 REGULATION FD DISCLOSURE

ITEM 7.01 REGULATION FD DISCLOSURE On September 10, 2024, members of Centene Corporation's (the "Company") senior management team will meet with investors. Consistent with the Company's guidance previously provided on September 4, 2024, the senior management team plans to: reaffirm the Company's 2024 full year adjusted diluted earnings per share (EPS) guidance of greater than $6.80; reiterate the shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4. Therefore, the Company projects Q3 adjusted diluted EPS of between $1.31 to $1.41, with the remainder of the 2024 full year adjusted diluted EPS to be realized in Q4; and reiterate that, with regard to Medicare Advantage, the Company continues to be encouraged by the progress it has made in the improvement of its stars program performance. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The Company strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-GAAP financial measures used by the Company may differ from similar measures used by other companies, even when similar terms are used to identify such measures. The presentation of non-GAAP financial measures is not intended to be

Forward-Looking Statements

Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this Form 8-K are forward-looking statements.Without limiting the foregoing, forward-looking statements often use words such as "guidance," "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, competition, expected contract start dates and terms, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievement

View Full Filing

View this 8-K filing on SEC EDGAR